| Metric | Current Period | Same Period Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥874.9B | ¥807.3B | +8.4% |
| Operating Income | ¥75.3B | ¥72.4B | +3.9% |
| Ordinary Income | ¥83.5B | ¥76.4B | +9.2% |
| Net Income | ¥63.4B | ¥56.0B | +13.2% |
| ROE | 4.6% | 4.3% | - |
Revenue and all four profit indicators increased, resulting in higher revenue and higher profits. Revenue was ¥874.9B (+8.4% YoY), Operating Income was ¥75.3B (+3.9%), Ordinary Income was ¥83.5B (+9.2%), and Net Income attributable to owners of the parent was ¥63.4B (+13.2%). Profit growth accelerated progressively down the income statement, reflecting an increase in non-operating income and a decline in the effective tax rate. EPS was ¥178.91 (¥158.11 in the previous year, +13.2%).
【Revenue】The Company operates in a single segment, the pharmaceutical-related business, and does not disclose a segment-level breakdown. Revenue increased by +8.4% YoY to ¥874.9B, representing a progress rate of 75.8% against the full-year forecast of ¥1155.0B. As the qualitative information does not specify concrete factors behind the revenue increase, the result can be viewed as company-wide growth.
【Profit and Loss】The gross profit margin was 47.8%, down 3.5pt from 51.4% in the previous year, as Cost of Sales growth (+16.2%) exceeded Revenue growth (+8.4%). Meanwhile, the SG&A expense ratio improved to 39.2% from 42.4% in the previous year, a 3.2pt improvement, partially offsetting the impact of the higher cost ratio. As a result, Operating Income was ¥75.3B (+3.9%), and the Operating Income margin was 8.6%, slightly down from 9.0% in the previous year. Ordinary Income was ¥83.5B (+9.2%), exceeding Operating Income growth, due to contributions from equity in earnings of affiliates of ¥5.9B and an increase in dividend income of ¥4.5B. Extraordinary income and extraordinary losses were both ¥0.02B, and the impact of temporary factors was limited. Net Income was ¥63.4B (+13.2%), exceeding Ordinary Income growth, primarily because the effective tax rate declined from 26.5% in the previous year to 24.0%. Although the Company was affected by higher costs at the operating level, increased non-operating income and a lower tax burden boosted bottom-line growth, resulting in higher revenue and higher profits.
【Profitability】Against Revenue of ¥874.9B (+8.4% YoY), the gross profit margin was 47.8%, down from 51.4% in the previous year by 3.5pt, indicating the impact of higher costs. Meanwhile, the SG&A expense ratio improved to 39.2% from 42.4% in the previous year by 3.2pt, allowing the Operating Income margin to be maintained at 8.6%, slightly below 9.0% in the previous year. The Net Income margin was 7.2%, improving from 6.9% in the previous year, reflecting the positive impact of non-operating items and the tax burden.【Cash Flow Quality】Cash and deposits were ¥385.0B, down ¥66.5B from ¥451.5B in the same period of the previous year. Accounts receivable increased to ¥402.0B, equivalent to 45.9% of Revenue versus 39.2% in the previous year, indicating that working capital has accumulated at a pace exceeding sales growth. Meanwhile, inventories were ¥205.1B, or 23.4% of Revenue, essentially unchanged from 25.6% in the previous year.【Investment Efficiency】ROE was 4.6% on a nine-month cumulative basis, while the total asset turnover ratio declined slightly to 0.48x from 0.50x in the previous year. Total assets increased by +13.8% YoY to ¥1822.2B, including a substantial increase in investment securities to ¥376.6B (+150.7%), which contributed to the decline in asset efficiency.【Financial Soundness】The Equity Ratio was 75.4%, down from 81.6% in the previous year, but remained at a high level. Interest-bearing debt consisted solely of ¥100.0B in long-term borrowings, newly raised during the period, while the current ratio was 401.2% (current assets of ¥1204.9B/current liabilities of ¥300.3B), indicating strong short-term payment capacity.
As the statement of cash flows is not included in the dataset, cash flow trends are analyzed based on changes in the balance sheet. Cash and deposits were ¥385.0B, down ¥66.5B from ¥451.5B in the same period of the previous year. The increase in investment securities (+¥226.4B) appears to have been the main source of cash outflow, while the increase in accounts receivable (+¥85.9B) may also have placed pressure on working capital. On the other hand, the increase in accounts payable (+¥64.9B) and the newly raised ¥100.0B in long-term borrowings provided financial support. Given the recognition of Net Income of ¥63.4B and the ¥35.1B increase in retained earnings to ¥1196.2B, the Company continues to generate profits from its core operations. However, the increased allocation of funds to investment securities and the rise in working capital have reduced cash on hand.
Extraordinary income and extraordinary losses were both ¥0.02B, and the difference between Ordinary Income and Net Income was primarily attributable to changes in income tax expense, indicating a limited impact from temporary factors. Non-operating income of ¥12.2B was mainly driven by dividend income of ¥4.5B (¥3.9B in the previous year) and equity in earnings of affiliates of ¥5.9B. Non-operating expenses of ¥4.0B included a foreign exchange loss of ¥2.5B. Ordinary Income growth (+9.2%) exceeded Operating Income growth (+3.9%) because of the increases in equity in earnings of affiliates and dividend income. Furthermore, Net Income growth (+13.2%) exceeded Ordinary Income growth because the effective tax rate declined from 26.5% in the previous year to 24.0% in the current period. Comprehensive income was ¥95.7B, ¥32.3B higher than Net Income of ¥63.4B, primarily due to a +¥33.6B valuation difference on other securities (OCI). Accordingly, the increase in comprehensive income was largely attributable to the fair-value measurement of held securities and should be distinguished from recurring earnings power in the core business.
Progress against the full-year earnings forecast was 75.8% for Revenue (¥874.9B/¥1155.0B), 79.2% for Operating Income (¥75.3B/¥95.0B), 75.9% for Ordinary Income (¥83.5B/¥110.0B), and 75.5% for Net Income (¥63.4B/¥84.0B). These levels are broadly in line with or slightly above the time-based progress rate of approximately 75% after nine months, indicating generally steady progress toward the full-year forecasts. No revisions were announced to the earnings forecast or dividend forecast, and management expects to achieve its initial plans.
Dividends have remained broadly unchanged. An interim dividend of ¥40 per share was paid at the end of Q2, and the full-year dividend forecast also remains ¥40 per share, with no revision to the dividend forecast. Based on the Company’s forecast EPS of ¥236.95, the forecast payout ratio is expected to be 40 yen ÷ ¥236.95 = 16.9%. Given the ample cash and deposits of ¥385.0B and the low level of borrowings, with interest-bearing debt of ¥100.0B, no significant concerns are apparent regarding dividend sustainability. No share repurchase was identified in this document, and dividends remain the primary form of shareholder returns.
Increase in trade receivables and cash collection cycle: Accounts receivable were ¥402.0B, up +27.2% YoY, while the ratio to Revenue increased by +6.8pt to 45.9% from 39.2% in the previous year, indicating that working capital has accumulated at a pace exceeding sales growth (+8.4%).
Valuation risk for investment securities: Investment securities increased by +150.7% YoY to ¥376.6B, while the valuation difference on other securities was +¥33.6B (OCI), boosting comprehensive income. Valuation gains may contract or reverse due to market fluctuations.
Incurrence of new interest-bearing debt: ¥100.0B in long-term borrowings was newly recorded. The use of funds and future trends in interest expense (¥0.3B) should be monitored.
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Income Margin | 8.6% | -218.2% (-628.8%–-14.9%) | +226.8pt |
| Net Income Margin | 7.2% | -216.8% (-725.8%–-24.6%) | +224.1pt |
| The Company’s Operating Income margin and Net Income margin both substantially exceeded the industry median, highlighting its strong profitability. |
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 8.4% | -12.5% (-22.1%–-2.5%) | +20.9pt |
| The Company’s Revenue growth rate substantially exceeded the industry median, which was in negative-growth territory, indicating relatively strong revenue growth within the industry. |
※Source: Compiled by the Company
The gross profit margin declined by -3.5pt YoY to 47.8%, indicating pressure from higher costs. Meanwhile, the SG&A expense ratio improved by -3.2pt, supporting Operating Income. Changes in the cost structure were reflected in a slight decline in the Operating Income margin to 8.6% from 9.0% in the previous year.
Ordinary Income (+9.2%) and Net Income (+13.2%) exceeded Operating Income growth (+3.9%). The increases in equity in earnings of affiliates (¥5.9B) and the decline in the effective tax rate (26.5%→24.0%) indicate that non-operating and tax-related factors boosted bottom-line profit beyond the growth of the core operating business.
Comprehensive income of ¥95.7B exceeded Net Income of ¥63.4B by +¥32.3B (+50.9%), primarily due to the valuation difference on held securities (+¥33.6B). In assessing earnings quality, it is important to note that this period’s profit growth included fair-value measurement factors in addition to core business performance.
This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly available earnings data. Investment decisions should be made at your own discretion and responsibility, and you should consult a professional as necessary.
---End of Report---
These are mechanically computed values based on a residual income model. They are not a forecast of market prices or a recommendation of any investment action, and do not predict or guarantee future share prices. Historical values are computed retrospectively using current guidance-achievement statistics.